Cerenome Q3 2026 Results: Net Loss of $8.66M, Loss Widens
Cerenome, Inc. reported a net loss of $24.6 million for the nine months ended September 30, 2026, compared to a $16.7 million loss in the prior year period. While the company introduced diagnostic revenue of $0.7 million, total revenue decreased due to lower grant revenue, and operating expenses nearly doubled to $25.8 million.
- Key figure
- Net loss $8.66M